Predict your next investment

HEALTHCARE | Drug Development
cytognos.com

See what CB Insights has to offer

Stage

Leveraged Buyout | Acquired

Total Raised

$3.02M

About Cytognos

Provider of reagents and software for analysis of flow cytometry. The company offers monocolonal antibodies, isotypic controls, lymphocytosis studies, and multiple myeloma reagents. The products are used to detect haematological cancers.

Cytognos Headquarter Location

Poligono La Serna, Nave 9 Santa Marta de Tormes

Salamanca, 37900,

Spain

34 92 312 5067

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cytognos

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cytognos is included in 1 Expert Collection, including Biopharmaceuticals.

B

Biopharmaceuticals

5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Cytognos Patents

Cytognos has filed 1 patent.

The 3 most popular patent topics include:

  • Bioinformatics
  • Dosage forms
  • Drug delivery devices
patents chart

Application Date

Grant Date

Title

Related Topics

Status

6/9/2017

11/20/2018

Dosage forms, Molecular biology, Drug delivery devices, Bioinformatics, Machine learning

Grant

Application Date

6/9/2017

Grant Date

11/20/2018

Title

Related Topics

Dosage forms, Molecular biology, Drug delivery devices, Bioinformatics, Machine learning

Status

Grant

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.